Cellular and proteomic changes following administration of peresolimab in patients with rheumatoid arthritis: a post-hoc analysis of a randomised phase 2a trial

The Lancet Rheumatology · Elsevier

Аннотация

Publication date: November 2026 Source: The Lancet Rheumatology, Volume 8, Issue 11 Author(s): Robert J Benschop, Jay L Tuttle, Paul Emery, Christoph Preuss, Ching-Yun Chang, Evan B Wang, Narayanan B Perumal, Jonathan T Sims, Ernst R Dow, Ajay Nirula, Pia P Yachi

Читать у издателя →

Похожие статьи